Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis US Share of Non-Current Assets by Year
US Share of Non-Current Assets (%) (%)
Novartis US Share of Non-Current Assets: 53.0% in FY2025, down 2.0 pts from a year earlier.
Latest, FY2025
53.0%
Period ended Dec 31, 2025
Change on a year earlier
-2.0 pts
55.0% in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | US Share of Non-Current Assets (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 53.0% | -2.0 pts | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 55.0% | 0.0 pts | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 55.0% | +7.0 pts | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2022 | Dec 31, 2022 | 48.0% | 0.0 pts | Novartis Form 20-F (0001370368-24-000004) ↗ |
| FY2021 | Dec 31, 2021 | 48.0% | +4.0 pts | Novartis Form 20-F/A (0001370368-23-000048) ↗ |
| FY2020 | Dec 31, 2020 | 44.0% | +7.0 pts | Novartis Form 20-F (0001370368-22-000010) ↗ |
| FY2019 | Dec 31, 2019 | 37.0% | -3.0 pts | Novartis Form 20-F (0001370368-21-000006) ↗ |
| FY2018 | Dec 31, 2018 | 40.0% | +10.0 pts | Novartis Form 20-F (0001370368-20-000003) ↗ |
| FY2017 | Dec 31, 2017 | 30.0% | – | Novartis Form 20-F (0001370368-19-000002) ↗ |
Cite this data
StockData. (2026). Novartis US Share of Non-Current Assets (%), annual FY2017–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-nca-us-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.